Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0· v2
Ependymoma Hub
V1V2
Sign in
← Cases

Darovasertib

ca27d343-1108-56dd-ba58-617084083ac4 · Phase III FDA Trials · targets PKCA, PKCB1, PKCB2, PKCD, PKCEPSILON, PKCETA, PKCG, PKCIOTA, PKCMU_PRKD1, PKCNU_PRKD3, PKCTHETA, PKCZETA

Darovasertib

MeasuredReference

Darovasertib targets PKCD, PKCTHETA, PKCEPSILON.

Primary targets

PKCDPKCTHETAPKCEPSILONPKCETAPKCB2

Top hallmarks

No hallmark data.

Top pathways disrupted

No pathway data.

Resistance landscape — Darovasertib

MeasuredReference

No variant annotations found on Darovasertib's top targets.

No variant annotations on Darovasertib's top targets.
Open in new tab